Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Fluorescite for Urine Sample Authenticity
NCT04071080Phase 1Completed
- Sponsor
- UPTru
- Start
- Aug 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Fluorescite with Placebo (2 arms). Primary endpoint: Percentage of patients with detectable urine fluorescence using an ophtalmoscope equipped with a cobalt blue filter at 30 months. Started Aug 2019; status: completed.
02
Drugs
fluorescein disodium
Beyond the preview
Go deeper on NCT04071080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04071080.